Education Background
- 2001 Board Certified Pharmacotherapy Specialist (BCPS)
Board of Pharmacy Specialties, American Pharmacists Association
- 2001 Specialized Residency in Pharmacotherapy
University of Texas Health Science Center, San Antonio, TX, USA
- 2000 Pharmacy Practice Residency
Florida Hospital, Orlando, FL, USA
- 1999 Doctor of Pharmacy
University of Florida, Gainesville, FL, USA
- 1994 Bachelor of Science in Pharmacy
Mahidol University, Bangkok, Thailand
Work Experience
- 2001 – 2002 Medical Intensive Care/Cardiac Care Unit Pharmacist
University of Utah Hospital and Clinics, Salt Lake City, UT
- 1999 – 2000 Clinical Pharmacist
Florida Hospital, Orlando, FL
- 1996 – 1997 Assistant Manager and Staff Pharmacist
Pharma 9 Community Pharmacy, Co.Ltd., Surin, Thailand
- 1994 – 1996 Head of Pharmacy Department
Sanom Community Hospital, Surin, Thailand
Expertise
- Evaluation of efficacy and safety of drugs on cardiovascular system.
- Pharmaceutical care for patients with cardiovascular diseases.
- Outcome research and evidence synthesis.
- Pharmacy practice research to assess contribution of pharmacists on health services.
Award & Honor
- Nagai Award Thailand for Research in Pharmacy Practice / Social Administrative Pharmacy
Nagai Foundation Tokyo, March 2022
- Research Award in the Field of Medical Science
National Research Council of Thailand, January 2019
- Teacher of the Year Award
Faculty of Pharmacy, Mahidol University, July 2016
- Young Investigator Grant
Mahidol University, Bangkok, Thailand, January 2006
- Graduation with highest honor, Doctor of Pharmacy degree
University of Florida, Gainesville, FL. May 1999 - Outstanding Minority Student Award
University of Florida, Gainesville, FL. April 1999 - International Students Awards
University of Florida, Gainesville, FL. April 1999 - Scholarship, Doctor of Pharmacy, granted by the Royal Thai Government
Thailand. October 1996 - Best performance, Fifth year student projects
Mahidol University, Bangkok, Thailand. March 1993
Current Research
Phetroong S, Nathisuwan S, Chindavijak B, Phrommintikul A, Sapoo U, Sookananchai B, Priksri W, Lip GYH. Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long-term warfarin therapy. Br J Clin Pharmacol. 2022 Sep 21. doi: 10.1111/bcp.15540.
Trerayapiwat K, Jinatongthai P, Vathesatogkit P, Sritara P, Paengsai N, Dilokthornsakul P, Nathisuwan S, Le LM, Chaiyakunapruk N. Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand. The Lancet Regional Health - Western Pacific 2022;26: 100503. https://doi.org/10.1016/j.lanwpc.2022.100503.
Rattanavipanon W, Chaiyasothi T, Puchsaka P, Mungkornkaew R, Nathisuwan S, Veettil SK, Chaiyakunapruk N. Effects of pharmacist interventions on cardiovascular risk factors and outcomes: An umbrella review of meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2022 Jul;88(7): 3064-3077. doi: 10.1111/bcp.15279.
Wattanaruengchai P, Nathisuwan S, Karaketklang K, Wongcharoen W, Phrommintikul A, Lip GYH. Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants. Br J Clin Pharmacol. 2022 May;88(5):2203-2212. doi: 10.1111/bcp.15145
Phrommintikul A, Nathisuwan S, Gunaparn S, Krittayaphong R, Wongcharoen W, Sehmi S, Mehta S, Winkles N, Brocklehurst P, Mathers J, Jowett S, Jolly K, Lane D, Thomas GN, Lip GYH; TREATS-AF Study Group. Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT 2 R 2 score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): a study protocol. BMJ Open
. 2021 Oct 11;11(10):e051987. doi: 10.1136/bmjopen-2021-051987.
Rattanavipanon W, Sotananusak T, Yamaae F, Chandrsawang A, Kaewkan P, Nathisuwan S, Yingchoncharoen T. Real-world experience of angiotensin receptor/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis. BMC Cardiovasc Disord. 2021 Jul 2;21(1):324. doi: 10.1186/s12872-021-02145-9.
Watanabe AH, Navaravong L, Sirilak T, Prasitwarachot R, Nathisuwan S, Page RL 2nd, Chaiyakunapruk N. A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids. J Am Pharm Assoc (2003). Sep-Oct 2021;61(5):e1-e13. doi: 10.1016/j.japh.2021.03.013.
Noviyani R, Youngkong S, Nathisuwan S, Bagepally BS, Chaikledkaew U, Chaiyakunapruk N, McKay G, Sritara P, Attia J, Thakkinstian A. Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis. BMJ Evid Based Med. 2021 Oct 11;bmjebm-2020-111634. doi: 10.1136/bmjebm-2020-111634.
Rattanavipanon W, Nithiphongwarakul C, Sirisuwansith P, Chaiyasothi T, Thakkinstian A, Nathisuwan S, Pathomwichaiwat T. Effect of tomato, lycopene and related products on blood pressure: A systematic review and network meta-analysis. Phytomedicine. 2021 Jul 15;88:153512. doi: 10.1016/j.phymed.2021.153512.
Wulandari UA, Kristina SA, Chindavijak B, Chulavatnatol S, Nathisuwan S. Educational program to improve hypertension knowledge by a community pharmacist in a rural district in Indonesia. J Am Coll Clin Pharm 2021;1–7. doi: 10.1002/jac5.1419
Arunmanakul P. Kengkla K, Chaiyasothi T, Phrommintikul A, Ruengorn C, Permsuwan U, Thakkinstian A, Page II RL, Munger MA, Nathisuwan S, Chaiyakunapruk N. Effects of pharmacist interventions on heart failure outcomes: A systematic review and meta?analysis. J Am Coll Clin Pharm 2021. doi: 10.1002/jac5.1442
Publication
Year 2026
Ho HTT, Vo HT, Tragulpiankit P, Nathisuwan S.
Clin Transl Sci 2025 Mar 4 , 2026.
Year 2025
Anticoagulation intensity and outcomes among southeast-Asians with moderate-to-severe mitral valve stenosis
Puchsaka P, Rattanavipanon W, Phetroong S, Ue-Sethasakdhi R, Wattanasombat S, Wongtheptien W, Nathisuwan S.
British Journal of Clinical Pharmacology 2025 Mar 10 , 2025.
Building the U.S.-ASEAN Consortium for Pharmacy Education based on the U.S.-Thai Consortium experience: a qualitative study
Sookaneknun Olson P, Nathisuwan S, Katz MD, Srimongkon P, Jungnickel PW, Ploylearmsang C, Leelathanalerk A, Ryan M, Doungngern T, Oderda GM, Lau AH, Pattharachayakul S, Wattanachai P, Nimworapan M, Seesin T, Potisarach P.
J Pharm Policy Pract 2025 Dec 2;18(1):2593123 , 2025.
Cost-Utility Analysis of Genomic Profiling in Directing Targeted Therapy in Advanced NSCLC in Thailand
Turongkaravee S, Nathisuwan S, Baisamut T, Meanwatthana J.
Appl Health Econ Health Policy 2025 Feb 7 , 2025.
Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis
Wai HS, Pathomwichaiwat T, Suansanae T, Nathisuwan S, Rattanavipanon W.
BMC Complement Med Ther 2025 Jul 29;25(1):292 , 2025.
Year 2024
Huynh BH; Vo HT; Pham ATK; Tragulpiankit P; Huynh NH; Nguyen NL; Nguyen LT; Hong Pham T; Nathisuwan S.
JACCP Journal of the American College of Clinical Pharmacy 2024; 7():544-553 , 2024.
Establishment of post-percutaneous coronary intervention (post-PCI) clinic in Thailand
Manapattanasatien T; Phanthumetamat N; Kanaderm C; Kehasukcharoen W; Rattanavipanon W; Nathisuwan S; Chaiyasothi T.
JACCP Journal of the American College of Clinical Pharmacy 2024; 7():1179-1187 , 2024.
Phrommintikul A; Nathisuwan S; Wongcharoen W; Krittayaphong R; Gunaparn S; Wongthanee A; Mathers J; Jowett S; Jolly K; Lane DA; Thomas GN; Lip GYH; Thomas GN; Krittiyaphong R; Slinn G; Sehmi S; Permsuwan U; Jiraporncharoen W; Angkurawaranon C; Slade A; Mehta S; Winkle N; Songmuang SB; Kunjara Na Ayudhya R; Yenn-Jiang L; Thongsri T; Liabsuetrakul T; Preedalikit K; Chantrarat T; Wongtheptien W; Wattanasombat S; Kaewdam J; Mananusorn N; Sawatna W; Chotayaporn T; Lertthanaphol K; Pothongsunun B; Chandee J; Prasit T; Ruttanapornnukul C; Sripattanatrakul K; Cheingyothakul V; Prasertwitayakij N; Niwatananun K; Silavanich V; Nimworapan M; Somsap P; Pornwisrtsirikul T; Daoram P; Srisongmuang C; Bureekam N; Intharangsri S; Kawila C; Winigkul A; Kaolawanich Y; Sarapakdi A; Pienpattapong U; Chaiphet O; Sookananchai B; Niyomsiriwanich P; Wiwatworapan W; Sapoo U; Kowitphattana S; Sae-Ueng K; Jirapermpun A; Senthong V; Onsanit S; Jantharuechai S; Tipboonchu W.
JACC: Asia 2024; ():- , 2024.
Dewi PEN; Youngkong S; Sunantiwat M; Nathisuwan S; Thavorncharoensap M.
BMJ Open 2024 Oct 14;19:10341-10365 , 2024.
Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women: Global Trends and Projections to 2040
Danpanichkul P, Ng CH, Muthiah MD, Duangsonk K, Kongarin S, Srisurapanont K, Pingwang P, Songmueang N, Nonthasoot C, Manosroi W, Nathisuwan S, Li F, Yang JD, Chen VL, Kim D, Noureddin M, Huang DQ, Wijarnpreecha K.
Mayo Clin Proc 2024 Mar 28:S0025-6196(24)00035-1 , 2024.
The burden of alcohol-related cardiovascular complications in young and middle-aged adults: rising burden of atrial fibrillation and hypertensive heart disease
Danpanichkul P, Wattanachayakul P, Duangsonk K, Ongsupankul S, Sripusanapan A, Uawithya E, Benjanuwattra J, Trongtorsak A, Nathisuwan S, Navaravong L.
Acta Cardiol 2024 May 3:1-8 , 2024.
Dewi PEN; Sunantiwat M; Thavorncharoensap M; Youngkong S; Nathisuwan S; Rahajeng B.
PLoS ONE 2024; (e0302320):- , 2024.
Kengkla K; Nathisuwan S; Sripakdee W; Saelue P; Sengnoo K; Sookprasert A; Subongkot S.
JCO global oncology 2024 Feb;10:e2300353 , 2024.
Year 2023
Characterization of drug-related problems and evaluation of pharmacist interventions in the cardiovascular intensive care settings in Thailand
Wattanaruengchai P, Kongwatcharapong J, Nathisuwan S.
JACCP Journal of the American College of Clinical Pharmacy , 2023.
Huynh BH; Nathisuwan S; Tragulpiankit P; Nguyen VD; Huynh NH; Vu TLA; Huynh LTH; Vo HT.
Journal of Pharmacy Technology 2023 Dec;39(6):259-268 , 2023.
Pathomwichaiwat T; Jinatongthai P; Prommasut N; Ampornwong K; Rattanavipanon W; Nathisuwan S; Thakkinstian A.
PLoS ONE 2023 Feb;89(2):843-852 , 2023.
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women
Danpanichkul P, Ng CH, Muthiah M, Suparan K, Hao Tan DJ, Duangsonk K, Sukphutanan B, Kongarin S, Harinwan N, Panpradist N, Takahashi H, Kawaguchi T, Vichitkunakorn P, Chaiyakunapruk N, Nathisuwan S, Huang D, Arab JP, Noureddin M, Mellinger JL, Wijarnpreecha K.
Am J Gastroenterol 2023 Dec 26 , 2023.
Syeed MS, Nonthasawadsri T, Nelson RE, Chaiyakunapruk N, Nathisuwan S.
Am J Cardiovasc Drugs 2023 Feb 3 , 2023.
Meakleartmongkol T; Tangpanithandee S; Vanavivit N; Jiso A; Pongchaikul P; Kirdlarp S; Khemawoot P; Nathisuwan S.
PloS one 2023 Nov 16;18(11):e0293866 , 2023.
Kongwatcharapong J; Sornkhamphan A; Kaveeta C; Nathisuwan S.
BMC Neurology 2023 Aug 5;208:211-220 , 2023.
Year 2022
Wattanaruengchai P, Nathisuwan S, Karaketklang K, Wongcharoen W, Phrommintikul A, Lip GYH.
British Journal of Clinical Pharmacology 2022 May;88(5):2203-2212 , 2022.
Phetroong S, Nathisuwan S, Chindavijak B, Phrommintikul A, Sapoo U, Sookananchai B, Priksri W, Lip GYH.
Br J Clin Pharmacol 2022 Sep 21 , 2022.
Noviyani R, Youngkong S, Nathisuwan S, Bagepally BS, Chaikledkaew U, Chaiyakunapruk N, McKay G, Sritara P, Attia J, Thakkinstian A.
BMJ Evid Based Med 2022 Aug;27(4):215-223 , 2022.
Rattanavipanon W, Chaiyasothi T, Puchsaka P, Mungkornkaew R, Nathisuwan S, Veettil SK, Chaiyakunapruk N.
British Journal of Clinical Pharmacology 2022 Jul;88(7):3064-3077 , 2022.
Trerayapiwat K, Jinatongthai P, Vathesatogkit P, Sritara P, Paengsai N, Dilokthornsakul P, Nathisuwan S, Le LM, Chaiyakunapruk N.
Lancet Reg Health West Pac 2022; 32(100503):- , 2022.
Year 2021
Educational program to improve hypertension knowledge by a community pharmacist in a rural district in Indonesia
Wulandari UA, Kristina SA, Chindavijak B, Chulavatnatol S, Nathisuwan S*..
JACCP journal of the american college of clinical pharmacy 2021; 4(6): 711-717., 2021.
Effect of tomato, lycopene and related products on blood pressure: A systematic review and network meta-analysis
Rattanavipanon W, Nithiphongwarakul C, Sirisuwansith P, Chaiyasothi T, Thakkinstian A, Nathisuwan S, Pathomwichaiwat T*..
Phytomedicine 2021; 88: 153512., 2021.
Effects of pharmacist interventions on heart failure outcomes: A systematic review and meta-analysis
Arunmanakul P, Kengkla K, Chaiyasothi T, Phrommintikul A, Ruengorn C, Permsuwan U, Thakkinstian A, Page RL, II, Munger MA, Nathisuwan S, Chaiyakunapruk N*..
JACCP Journal of the American College of Clinical Pharmacy 2021; 4(7): 871-882., 2021.
Knowledge of stroke and medication adherence among patients with recurrent stroke or transient ischemic attack in Indonesia: a multi-center, cross-sectional study
Widjaja KK, Chulavatnatol S, Suansanae T, Wibowo YI, Sani AF, Islamiyah WR, Nathisuwan S*..
Int J Clin Pharm 2021; 43(3): 666-672., 2021.
Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand
Wattanaruengchai P, Nathisuwan S*, Rattanavipanon W, Chulavatnatol S, Kongwatcharapong J, Mitsuntisuk P, Chaiyasothi T, Kritsanapipat D, Phrommintikul A, Chaiyakunapruk N, Likittanasombat K, Lip GYH..
British journal of clinical pharmacology 2021; 87(3): 1390-1400., 2021.
Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT 2 R 2 score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): A study protocol
Phrommintikul A, Nathisuwan S, Gunaparn S, Krittayaphong R, Wongcharoen W, Sehmi S, Mehta S, Winkles N, Brocklehurst P, Mathers J, Jowett S, Jolly K, Lane D, Thomas GN, Lip GYH*..
BMJ Open 2021; 11(10): e051987., 2021.
Real-world comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in a developing country
Mitsuntisuk P, Nathisuwan S*, Junpanichjaroen A, Wongcharoen W, Phrommintikul A, Wattanaruengchai P, Rattanavipanon W, Chulavatnatol S, Chaiyakunapruk N, Likittanasombat K, Lip GYH..
Clinical Pharmacology and Therapeutics 2021; 109(5): 1282-1292., 2021.
Real-world experience of angiotensin receptor/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis
Rattanavipanon W, Sotananusak T, Yamaae F, Chandrsawang A, Kaewkan P, Nathisuwan S, Yingchoncharoen T*..
BMC Cardiovascular Disorders 2021; 21(1): 324., 2021.
Year 2020
Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis.
Ng SS, Lai NM, Nathisuwan S, Jahan NK, Dilokthornsakul P, Kongpakwattana K, Hollingworth W, Chaiyakunapruk N*..
Scientific reports 2020; 10(1): 662., 2020.
Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation
Dilokthornsakul P, Nathisuwan S, Krittayaphong R, Chutinet A, Permsuwan U*..
Heart lung and circulation 2020; 29(3): 390-400., 2020.
Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand
Ng SS, Nathisuwan S, Phrommintikul A, Chaiyakunapruk N*..
Thrombosis research 2020; 185: 63-71., 2020.
Knowledge of stroke and medication adherence among patients with recurrent stroke or transient ischemic attack in Indonesia: a multi‑center, cross‑sectional study
Widjaja KK, Chulavatnatol S, Suansanae T, Wibowo YI, Sani AF, Islamiyah WR, Nathisuwan S.
International Journal of Clincal Pharmacy 2020 Oct 29. doi: 10.1007/s11096-020-01178-y, 2020.
Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand
Wattanaruengchai P, Nathisuwan S, Rattanavipanon W, Chulavatnatol S, Kongwatcharapong J, Mitsuntisuk P, Chaiyasothi T, Kritsanapipat D, Phrommintikul A, Chaiyakunapruk N, Likittanasombat K, Lip GYH.
Br J Clin Pharmacol 2020 Aug 28. doi: 10.1111/bcp.14535, 2020.
Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand
Sukkha S, Rattanavipanon W, Chamroenwit B, Sanganurak M, Nathisuwan S, Chaikledkaew U, Kongwatcharapong J*..
International journal of clinical pharmacy 2020; 42(2): 610-616., 2020.
Real-world comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in a developing country
Mitsuntisuk P, Nathisuwan S, Junpanichjaroen A, Wongcharoen W, Phrommintikul A, Wattanaruengchai P, Rattanavipanon W, Chulavatnatol S, Chaiyakunapruk N, Likittanasombat K, Lip GYH.
Clin Pharmacol Ther 2020 Oct 28. doi: 10.1002/cpt.2090, 2020.
Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand
Chairat K, Rattanavipanon W, Tanyasaensook K, Chindavijak B, Chulavatnatol S, Nathisuwan S*..
Int J cardiol heart vasc 2020; 30: 100597., 2020.
Year 2019
Characteristic of drug-related problems and pharmacists’ interventions in a stroke unit in Thailand
Semcharoen K, Supornpun S, Nathisuwan S, Kongwatcharapong J*..
International Journal of Clinical Pharmacy -, 2019.
Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand
Kongpakwattana K, Ademi Z, Chaiyasothi T, Nathisuwan S*, Zomer E, Liew D, Chaiyakunapruk N..
Pharmacoeconomics 2019; 37(10); 1277-1286., 2019.
Dilokthornsakul P, Nathisuwan S, Krittayaphong R, Chutinet A, Permsuwan U*..
Heart Lung and Circulation -, 2019.
Effects of Non-statin Lipid-Modifying Agents on Cardiovascular Morbidity and Mortality Among Statin-Treated Patients: A Systematic Review and Network Meta-Analysis
Chaiyasothi T, Nathisuwan S, Dilokthornsakul P, Vathesatogkit P, Thakkinstian A, Reid C, Wongcharoen W, Chaiyakunapruk N..
FRONTIERS IN PHARMACOLOGY 2019;10:547, 2019.
Veettil SK, Nathisuwan S, Ching SM, Jinatongthai P, Lim KG, Kew ST, Chaiyakunapruk N..
Cancer Management and Research 2019; 11: 561-571., 2019.
Incidence, risk factors, and outcomes of warfarin-associated major bleeding in Thai population
Priksri W, Rattanavipanon W, Saejear W, Tanyasaensook K, Phrommintikul A, Chulavatnatol S, Nathisuwan S.
Pharmacoepidemiology and Drug Safety 2019;28:942-950, 2019.
Relationship of medication adherence and quality of life among heart failure patients
Silavanich V, Nathisuwan S, Phrommintikul A, Permsuwan U*..
Heart and Lung 2019; 48(2): 105-110., 2019.
Leong SL, Chaiyakunapruk N, Tassaneeyakul W, Arunmanakul P, Nathisuwan S*, Lee SWH..
International Journal of Cardiology 2019; 280: 190-197., 2019.
Year 2018
Chumnumwat S, Yi K, Lucksiri A, Nosoongnoen W, Chindavijak B, Chulavatnatol S, Sarapakdi A, Nathisuwan S*..
Cardiovascular Therapeutics 2018; 36(2): e12315, 2018.
Efficacy and safety of chemopreventive agents on colorectal cancer incidence and mortality: systematic review and network meta-analysis.
Veettil SK, Jinatongthai P, Nathisuwan S, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Reid CM, Chaiyakunapruk N.
Clinical Epidemiology 2018; 10: 1433-1445, 2018.
Ng SS, Lai NM, Nathisuwan S, Chaiyakunapruk N.*.
Clinical Drug Investigation 2018; 38(7): 579-591, 2018.
Relationship of medication adherence and quality of life among heart failure patients
Silavanich V., Nathisuwan S., Phrommintikul A., Permsuwan U*..
Heart and Lung 2018; (Article in Press), 2018.
Year 2017
Jinatongthai P, Kongwatcharapong J, Foo CY, Phrommintikul A, Nathisuwan S, Thakkinstian A, Reid CM, Chaiyakunapruk N*..
The Lancet 2017; 390(10096): 747-759., 2017.
Thuengern A, Nathisuwan S, Chomnawang MT, Wiwat C, Thirapanmethee K*..
Journal of Global Antimicrobial Resistance 2017; 9: 87-93., 2017.
Year 2016
Kongwatcharapong J, Dilokthornsakul P, Nathisuwan S, Phrommintikul A, Chaiyakunapruk N*..
International Journal of Cardiology. 2016; 211: 88-95., 2016.
Year 2015
Permsuwan U*, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A..
Heart Lung and Circulation 2015; 24(9): 860-868, 2015.
Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database
Win TSZ, Chaiyakunapruk N, Suwankesawong W, Dilokthornsakul P, Nathisuwan S*..
Asian pacific journal of allergy and immunology. 2015; 33(3): 227-235, 2015.
Year 2014
Thirapanmethee K*, Pothisamutyothin K., Nathisuwan S, Chomnawang MT, Wiwat C..
Microbiology and Immunology 2014; 58(12): 655-665, 2014.
Jinatongthai P, Khaisombut N, Likittanasombat K, Chaiyakunapruk N, Watcharathanakij S, Nathisuwan S*..
Heart Lung and Circulation 2014; 23(11): 1051-1058, 2014.
Year 2013
Characteristics of Renin Angiotensin System Blockers-induced Angioedema in Thailand
Win TSZ (Win, T. S. Z.), Nathisuwan S, Chaiyakunapruk N, Suwankesawong W, Tanyasaensook K, Dilokthornsakul P..
International journal of clinical pharmacy. 2013; 35(6): 1292-1292, 2013.
Boonmuang P, Nathisuwan S*, Chaiyakunapruk N, Suwankesawong W, Pokhagul P, Teerawattanapong N, Supsongserm P..
Drug Safety 2013; 36(9): 779-787, 2013.
Cost-Effectiveness of Pharmacist-Participated Warfarin Therapy Management in Thailand
Saokaew S, Permsuwan U, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A, Jeanpeerapong N.
Thrombosis Research 2013; 132(4): 437-443, 2013.
Cost-effectiveness of CYP2C9 and VKORC1 genetic testing to predict warfarin guided dose in Thai population
Salek S, Dumrongprat K, Nathisuwan S..
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 2013; 35(5): 1005-1005., 2013.
Boonmuang P, Nathisuwan S*, Chaiyakunapruk N, Suwankesawong W, Pokhagul P, Teerawattanapong N, Supsongserm P..
Drug Safety 2013; 36(7): 583-584, 2013.
Risk factors Related to Rhabdomyolysis in Thai Statin Users: A Case-control Study
Supsongserm P, Boonmuang P, Nathisuwan S, Chaiyakunapruk N, Tanyasaensook K*.
Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (4), 1-7, 2013.
Year 2012
Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand
Saokaew S, Sapoo U, Nathisuwan S, Chaiyakunapruk N,.
International Journal of Clinical Pharmacy 2012; 34(1): 105-112, 2012.
Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding
Saokaew S, Khaisombat N, Chaiyakunapruk N*, Likittanasombat K, Nathisuwan S..
Value in Health Regional Issues 2012; 1(1): 41-45, 2012.
Year 2011
Nathisuwan S, Dilokthornsakul P, Chaiyakunapruk N*, Morarai T, Yodting T, Piriyachananusorn N..
Chest 2011; 139(5): 1130-1139, 2011.
การดูแลตนเองเกี่ยวกับการใช้ยาของผู้สูงอายุโรคปอดอุดกั้นเรื้อรัง
พนิดา ไกรนรา, พรทิพย์ มาลาธรรม, สุรกิจ นาฑีสุวรรณ, ธีระศักดิ์ แก้วอมตะวงศ์.
รามาธิบดีพยาบาลสาร 2011; 17(2): 287-304., 2011.
Year 2010
Siriswangvat S,Sansanayudh N, Nathisuwan S, Panomvana D*..
Circ J 2010; 74(10): 2187-2192., 2010.
Saokaew S, Permsuwan U, Chaiyakunapruk N*, Nathisuwan S, Sukonthasarn A..
J Thromb Haemost 2010; 8(11): 2418-2427., 2010.
Year 2007
Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
Niruntraporn S, Chaiyakunapruk N*, Nathisuwan S, Thamlikitkul V..
Pharmacoepidemiology and Drug Safety. 2007; 16(9) Sep: 1031-1037., 2007.
Year 2006
The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis.
Chaiyakunapruk N*, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C..
Am J Obstet Gynecol 2006 Jan; 194(1): 95-9., 2006.
Year 2005
Prevention of adverse drug reactions in hospitalised patients by pharmacist participation at a large teaching hospital in Thailand.
Tragulpiankit P, Pummangura C, Luscombe DK, Kaojarern S, Wananukul W, Montakantikul P, Nathisuwan S..
Drug Safety 2005;28(10):931., 2005.
Year 2003
Faculty turnover within academic pharmacy departments.
Carter O, Nathisuwan S, Stoddard GJ, Munger MA..
Ann Pharmacother 2003; 37: 197-201, 2003.
Year 2002
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Burgess DS, Nathisuwan S..
Diagn Microbiol Infect Dis 2002; 44: 35-41, 2002.
Presentation
Year 2007
Impact of warfarin-monitoring service by a clinical pharmacist in patients undergoing cardiovascular and thoracic surgery.
S, Chulavatnatol S, Nathisuwan S, Thongcharoen P, Anansakunwatt W, Janthara-arpornkul U..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง ”The New Frontier of Pharmacy Practice” ณ อาคารเฉลิมพระบารมี ๕๐ ปี แพทยสมาคมฯ กรุงเทพฯ วันที่ 23 - 25 พฤษภาคม พ.ศ. 2550. 2007, 2007.
Year 2005
Impact of physician-pharmacist collaboration on dyslipidemia management in type 2 diabetic patients.
Tangjaideeborisut R, Nathisuwan S, Buranaosod S, Suksomboon N, Chulavatnatol S..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง “การจัดการระบบยาในโรงพยาบาลเพื่อความปลอดภัยของผู้ป่วย” กรุงเทพฯ วันที่ 25 - 27 พฤษภาคม พ.ศ. 2548. 2005, 2005.